Skip to main navigation Skip to search Skip to main content

Failure of daptomycin β-Lactam combination therapy to prevent resistance emergence in Enterococcus faecium

  • Vidthiya Menon
  • , Rebecca Davis
  • , Nick Shackel
  • , Bjorn A. Espedido
  • , Alicia G. Beukers
  • , Slade O. Jensen
  • , Sebastiaan J. van Hal

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

Daptomycin β-Lactam combination therapy offers "protection" against daptomycin non-susceptibility (DNS) development in Enterococcus faecium. We report failure of this strategy and the importance of source control. Mutations were detected in the LiaF and cls genes in DNS isolates. A single DNS isolate contained an unrecognized mutation, which requires confirmation.
Original languageEnglish
Pages (from-to)120-122
Number of pages3
JournalDiagnostic Microbiology and Infectious Disease
Volume90
Issue number2
DOIs
Publication statusPublished - Feb 2018

Bibliographical note

Publisher Copyright:
© 2017 Elsevier Inc.

Keywords

  • drug resistance in microorganisms
  • enterococcus

Fingerprint

Dive into the research topics of 'Failure of daptomycin β-Lactam combination therapy to prevent resistance emergence in Enterococcus faecium'. Together they form a unique fingerprint.

Cite this